NORTH CHICAGO, Ill., March 31, 2020 /PRNewswire/ -- AbbVie (NYSE:ABBV), a research-based global biopharmaceutical company, today announced a donation of $35 million to support COVID-19 relief efforts. In the U.S., AbbVie's funds will be used to support healthcare capacity for hospitals as...
from PR Newswire: https://ift.tt/2UwPrYB
No comments:
Post a Comment